-
1
-
-
0033590513
-
Treatment of asthma with drugs modifying the leukotriene pathway
-
Drazen JM, Israel E, O'Byrne P. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340: 197-206
-
(1999)
N. Engl. J. Med.
, vol.340
, pp. 197-206
-
-
Drazen, J.M.1
Israel, E.2
O'Byrne, P.3
-
2
-
-
0033011604
-
Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease
-
Busse WW, McGill KA, Horwitz RJ. Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 1999; 29 (S2): S110-5
-
(1999)
Clin. Exp. Allergy
, vol.29
, Issue.S2
-
-
Busse, W.W.1
McGill, K.A.2
Horwitz, R.J.3
-
3
-
-
0031047375
-
Leukotrienes in the pathogenesis of asthma
-
O'Byrne PM. Leukotrienes in the pathogenesis of asthma. Chest 1997; 111 (S2): S27-34
-
(1997)
Chest
, vol.111
, Issue.S2
-
-
O'Byrne, P.M.1
-
4
-
-
0023942170
-
Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin
-
Ferreri N, Howland WC, Stevenson DD, et al. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988; 137: 847-54
-
(1988)
Am. Rev. Respir. Dis.
, vol.137
, pp. 847-854
-
-
Ferreri, N.1
Howland, W.C.2
Stevenson, D.D.3
-
6
-
-
0031607546
-
The role of antileukotrienes in asthma management
-
Tan RA. The role of antileukotrienes in asthma management. Curr Opin Pulm Med 1998; 4 (1): 25-30
-
(1998)
Curr. Opin. Pulm. Med.
, vol.4
, Issue.1
, pp. 25-30
-
-
Tan, R.A.1
-
7
-
-
0031798623
-
Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors
-
Drazen J. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Am J Respir Crit Care Med 1998; 157: S233-7
-
(1998)
Am. J. Respir. Crit. Care Med.
, vol.157
-
-
Drazen, J.1
-
8
-
-
0031039964
-
Worldwide clinical experience with the first marketed leukotriene receptor antagonist
-
Barnes NC, Dejong B, Miyamoto T. Worldwide clinical experience with the first marketed leukotriene receptor antagonist. Chest 1997; 111 (S2): S52-60
-
(1997)
Chest
, vol.111
, Issue.S2
-
-
Barnes, N.C.1
Dejong, B.2
Miyamoto, T.3
-
9
-
-
0033574195
-
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma
-
Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. Ann Intern Med 1999; 130 (6): 487-95
-
(1999)
Ann. Intern. Med.
, vol.130
, Issue.6
, pp. 487-495
-
-
Malmstrom, K.1
Rodriguez-Gomez, G.2
Guerra, J.3
-
10
-
-
0030445953
-
Anti-leukotriene agents: A new direction in asthma therapy
-
Nathan RA. Anti-leukotriene agents: a new direction in asthma therapy. J Asthma 1996; 33 (6): 353-66
-
(1996)
J. Asthma.
, vol.33
, Issue.6
, pp. 353-366
-
-
Nathan, R.A.1
-
12
-
-
0032929887
-
Therapeutic advances: Leukotriene antagonists for the treatment of asthma
-
Misson J, Clark W, Kendall MJ. Therapeutic advances: leukotriene antagonists for the treatment of asthma. J Clin Pharm 1999; 24 (1): 17-22
-
(1999)
J. Clin. Pharm.
, vol.24
, Issue.1
, pp. 17-22
-
-
Misson, J.1
Clark, W.2
Kendall, M.J.3
-
13
-
-
0032522735
-
Montelukast for chronic asthma in 6- and 14-year old children: A randomized, double-blind trial
-
Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6- and 14-year old children: a randomized, double-blind trial. JAMA 1998; 279 (15): 1181-6
-
(1998)
JAMA
, vol.279
, Issue.15
, pp. 1181-1186
-
-
Knorr, B.1
Matz, J.2
Bernstein, J.A.3
-
15
-
-
0025341987
-
The effect of a leukotriene antagonist on the early response to antigen
-
Flowers BK, Proud D, Kagey-Sobotka A, et al. The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg 1990; 102: 219-24
-
(1990)
Otolaryngol. Head Neck Surg.
, vol.102
, pp. 219-224
-
-
Flowers, B.K.1
Proud, D.2
Kagey-Sobotka, A.3
-
16
-
-
0025685169
-
Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor
-
Knapp HR. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 1990; 323 (25): 1745-8
-
(1990)
N. Engl. J. Med.
, vol.323
, Issue.25
, pp. 1745-1748
-
-
Knapp, H.R.1
-
17
-
-
0028990176
-
The leukotriene d4-receptor antagonist, ici 204,219, relieves symptoms of acute seasonal allergic rhinitis
-
Donnelly AL, Glass M, Minkwitz MC, et al. The leukotriene d4-receptor antagonist, ici 204,219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995; 151: 1734-9
-
(1995)
Am. J. Respir. Crit. Care Med.
, vol.151
, pp. 1734-1739
-
-
Donnelly, A.L.1
Glass, M.2
Minkwitz, M.C.3
-
18
-
-
19244370387
-
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics
-
Dahlen B. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Care Med 1998; 157: 1187-94
-
(1998)
Am. J. Respir. Care Med.
, vol.157
, pp. 1187-1194
-
-
Dahlen, B.1
-
19
-
-
0024849260
-
Immunopathology of nasal polyps: An immunohistochemical approach
-
Larocca LM, Maggiano N, Capeli A, et al. Immunopathology of nasal polyps: an immunohistochemical approach. Ann Allergy 1989; 63: 508-51
-
(1989)
Ann. Allergy
, vol.63
, pp. 508-551
-
-
Larocca, L.M.1
Maggiano, N.2
Capeli, A.3
-
20
-
-
0023149914
-
Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa
-
Jung TTK, Juhn SK, Hwang D, et al. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 1987; 97: 184-8
-
(1987)
Laryngoscope
, vol.97
, pp. 184-188
-
-
Jung, T.T.K.1
Juhn, S.K.2
Hwang, D.3
-
22
-
-
0028884734
-
Arachidonic acid metabolites and sinonasal polyposis: I. Possible prognostic value
-
Klapan I, Culo F, Culig J, et al. Arachidonic acid metabolites and sinonasal polyposis: I. Possible prognostic value. Am J Otolaryngol 1995; 16 (6): 396-402
-
(1995)
Am. J. Otolaryngol.
, vol.16
, Issue.6
, pp. 396-402
-
-
Klapan, I.1
Culo, F.2
Culig, J.3
-
23
-
-
0029901768
-
Eicosanoids from biopsy of normal and polypous nasal mucosa
-
Baenkler HW, Schafer D, Hosemann W. Eicosanoids from biopsy of normal and polypous nasal mucosa. Rhinology 1996; 34 (3): 166-70
-
(1996)
Rhinology
, vol.34
, Issue.3
, pp. 166-170
-
-
Baenkler, H.W.1
Schafer, D.2
Hosemann, W.3
-
24
-
-
0032772316
-
Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics
-
Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Care Med 1999; 160: 291-6
-
(1999)
Am. J. Respir. Care Med.
, vol.160
, pp. 291-296
-
-
Picado, C.1
Fernandez-Morata, J.C.2
Juan, M.3
-
25
-
-
0032782372
-
Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease
-
American Rhinologic Society Spring Meeting; Palm Beach (FL) 1998
-
Ulualp SO, Sterman BM, Toohill RJ. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. American Rhinologic Society Spring Meeting; Palm Beach (FL) 1998. Ear Nose Throat J 1999; 72: 604-16
-
(1999)
Ear Nose Throat J.
, vol.72
, pp. 604-616
-
-
Ulualp, S.O.1
Sterman, B.M.2
Toohill, R.J.3
-
26
-
-
0033968891
-
Acute effects of antileukotrienes on sinusitis and sinonasal polyposis 1999
-
Parnes SM, Chuma AV. Acute effects of antileukotrienes on sinusitis and sinonasal polyposis 1999. Ear Nose Throat J 1999; 79: 18-25
-
(1999)
Ear Nose Throat J.
, vol.79
, pp. 18-25
-
-
Parnes, S.M.1
Chuma, A.V.2
-
27
-
-
0034846823
-
An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma
-
Ragab S, Parikh A, Darby YC, et al. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001; 31 (9): 1385-91
-
(2001)
Clin. Exp. Allergy
, vol.31
, Issue.9
, pp. 1385-1391
-
-
Ragab, S.1
Parikh, A.2
Darby, Y.C.3
-
28
-
-
0034764333
-
Treatment of ASS-associated polyposis (ASSAP) with a Cysteinyl leukotriene receptor antagonist: A prospective drug study on its antiinflammatory effects [in German]
-
Grundmann T, Topfner M. Treatment of ASS-associated polyposis (ASSAP) with a Cysteinyl leukotriene receptor antagonist: a prospective drug study on its antiinflammatory effects [in German]. Laryngorhinootologie 2001; 80 (10): 576-82
-
(2001)
Laryngorhinootologie
, vol.80
, Issue.10
, pp. 576-582
-
-
Grundmann, T.1
Topfner, M.2
-
29
-
-
0034305846
-
Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome
-
Di Rienzo L, Artuso A, Cerqua N. Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome. Acta Otorhinolaryngol Ital 2000; 20 (5): 336-42
-
(2000)
Acta Otorhinolaryngol. Ital.
, vol.20
, Issue.5
, pp. 336-342
-
-
Di Rienzo, L.1
Artuso, A.2
Cerqua, N.3
|